X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Strides Arcolab Fact Sheet, Strides Arcolab Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Strides Arcolab Fact Sheet   (PLLB)

Here is the latest financial fact sheet of Strides Arcolab. For more details, see the Strides Arcolab quarterly results and Strides Arcolab share price and chart. For a sector overview, read our pharmaceuticals sector report.

STRIDES SHASUN LTD Price History

Price Rs 941.3
Mkt Cap Rs m 56,146
Vol '000 15.5
P/E X 14.5
P/CF X 15.8
EPS (TTM) Rs 64.9
% ch % -0.0
No. of shares m 59.65
% ch week % -0.1
% ch 1-mth % 3.8
% ch 12-mth % -11.9
52 week H/L Rs 1,259.0/848.5
(As on Jun 23, 2017 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

STRIDES SHASUN LTD Financials

No. of Mths
Year Ending
12
Dec-11
*
12
Dec-12
*
15
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
STRIDES SHASUN LTD EQUITY SHARE DATA
High Rs4551,2251,1381,1991,413 
Low Rs276372344384848 
Sales per share (Unadj.) Rs436.8163.6225.1200.6353.3 
Earnings per share (Unadj.) Rs38.5143.9296.6141.723.4 
Diluted earnings per shareRs37.6141.9296.2141.735.0 
Cash flow per share (Unadj.) Rs56.3149.2306.1152.541.0 
Dividends per share (Unadj.) Rs2.002.00505.00108.005.00 
Adj. dividends per shareRs1.961.97504.32107.957.49 
Dividend yield (eoy) %0.50.368.213.70.4 
Book value per share (Unadj.) Rs233.2344.6169.0192.0320.4 
Adj. book value per shareRs228.2339.7168.8191.9480.0 
Shares outstanding (eoy) m58.3858.8059.5759.6289.35 
Bonus/Rights/Conversions  ESOPESOPESOPESOPESOP 
Price / Sales ratio x0.84.93.33.93.2 
Avg P/E ratio x9.55.52.55.648.3 
P/CF ratio (eoy) x6.55.42.45.227.6 
Price / Book Value ratio x1.62.34.44.13.5 
Dividend payout %5.21.4170.376.221.4 
Avg Mkt Cap Rs m21,33846,95844,13547,165100,988 
No. of employees `0003.02.71.52.04.7 
Total wages/salary Rs m3,0271,2031,5721,7214,988 
Avg. sales/employee Rs Th8,497.33,562.18,939.55,979.36,730.0 
Avg. wages/employee Rs Th1,008.8445.61,047.9860.31,063.6 
Avg. net profit/employee Rs Th748.03,134.211,778.34,225.0445.5 
STRIDES SHASUN LTD INCOME DATA
Net Sales Rs m25,5009,61813,40911,95931,564 
Other income Rs m3173426023861,212 
Total revenues Rs m25,8179,96014,01212,34432,776 
Gross profit Rs m4,9071,0062,2342,2895,213 
Depreciation Rs m1,0433095656401,573 
Interest Rs m1,9487951,0894741,803 
Profit before tax Rs m2,2322451,1831,5603,049 
Minority Interest Rs m-95-11-66127 
Prior Period Items Rs m0000-27 
Extraordinary Inc (Exp) Rs m4958,34019,7368,361-371 
Tax Rs m3871123,2451,476689 
Profit after tax Rs m2,2458,46217,6678,4502,089 
Gross profit margin %19.210.516.719.116.5 
Effective tax rate %17.345.5274.394.622.6 
Net profit margin %8.888.0131.870.76.6 
STRIDES SHASUN LTD BALANCE SHEET DATA
Current assets Rs m16,25314,10913,08614,29535,949 
Current liabilities Rs m27,91717,9737,07410,19919,402 
Net working cap to sales %-45.7-40.244.834.252.4 
Current ratio x0.60.81.81.41.9 
Inventory Days Days69168486371 
Debtors Days Days7718399119127 
Net fixed assets Rs m14,90115,6795,5067,35734,478 
Share capital Rs m584588596596894 
"Free" reserves Rs m11,56418,0394,5946,14022,601 
Net worth Rs m13,61420,26210,06811,44928,632 
Long term debt Rs m10,5437,3122,7552,67427,455 
Total assets Rs m53,64347,97520,99024,86176,591 
Interest coverage x2.11.32.14.32.7 
Debt to equity ratio x0.80.40.30.21.0 
Sales to assets ratio x0.50.20.60.50.4 
Return on assets %7.819.389.435.95.1 
Return on equity %16.541.8175.573.87.3 
Return on capital %19.034.0171.673.68.2 
Exports to sales %21.253.059.460.248.1 
Imports to sales %5.115.720.523.514.5 
Exports (fob) Rs m5,4055,0997,9597,20415,192 
Imports (cif) Rs m1,2901,5152,7522,8094,565 
Fx inflow Rs m6,3266,48222,79113,03116,612 
Fx outflow Rs m1,5141,8263,0883,1655,292 
Net fx Rs m4,8124,65619,7039,86511,320 
STRIDES SHASUN LTD CASH FLOW
From Operations Rs m 4,571 1,343 -2,717 834 717 
From Investments Rs m -6,565 8,065 40,771 519 -22,284 
From Financial Activity Rs m 894 -9,900 -33,185 -4,213 29,488 
Net Cashflow Rs m -1,100 -492 4,869 -2,860 8,073 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 27.7%
Foreign collaborators 0.0%
Indian inst/Mut Fund 37.8%
FIIs 8.6%
ADR/GDR 0.0%
Free float 25.9%
Shareholders 56,241
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 201, Devavrata, Sector 17, Vashi, Navi Mumbai - 400 705
E-MAIL badree.komandur@stridesarco.com WEB www.stridesarco.com
TELEPHONE (080) 6784 0000 FAX (080) 6784 0800
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Deloitte Haskins & Sells
CHM: Deepak Vaidya (MD) COMP SEC: Badree Komandur (EVP-Finance) YEAR OF INC: 1980 BSE CODE: 532531 FV (Rs): 10 DIV YIELD (%): 0.8

More Pharmaceuticals Company Fact Sheets:   NOVARTIS  J.B.CHEMICALS  DR. REDDYS LAB  PLETHICO PHARMA  IPCA LABS  

Compare STRIDES SHASUN LTD With:   NOVARTIS  J.B.CHEMICALS  DR. REDDYS LAB  PLETHICO PHARMA  IPCA LABS  

Compare STRIDES SHASUN LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Share Markets End the Week on a Dull Note(RoundUp)

Global financial markets ended the week on a dull note. This was on back of the Federal Reserve's release of its May 2-3 policy meeting minutes.

Views on news

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

More Views on News

Most Popular

A Pharma IPO in a Market That Loves IPOs but Hates Pharma(The 5 Minute Wrapup)

Jun 15, 2017

Tomorrow comes the IPO of Eris Lifesciences. How will a pharma IPO do in this market?

Bitcoin at $10,000?(Vivek Kaul's Diary)

Jun 14, 2017

Whether you're Venezuela or China or in India or the US...and you want to protect your wealth, you need real money. All the government has on offer is funny money.

Get Ready for Commodity Options!(Daily Profit Hunter)

Jun 16, 2017

Commodity options trading is one step closer to reality. Learn how to take advantage of this tremendous opportunity.

Walter Schloss' Investing Record(Chart Of The Day)

Jun 17, 2017

In a market full of one-hit-wonders, this investor obviously had a formula that worked. And through the think-and-thin of the market.

11 Hidden Costs Associated With Your Home Loan(Outside View)

Jun 16, 2017

Various costs associated with a home loan.

More

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD - MERCK LTD COMPARISON

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS